Vascular remodeling of the mouse yolk sac requires hemodynamic force
Abstract
The embryonic heart and vessels are dynamic and form and remodel while functional. Much has been learned about the genetic mechanisms underlying the development of the cardiovascular system, but we are just beginning to understand how changes in heart and vessel structure are influenced by hemodynamic forces such as shear stress. Recent work has shown that vessel remodeling in the mouse yolk sac is secondarily effected when cardiac function is reduced or absent. These findings indicate that proper circulation is required for vessel remodeling, but have not defined whether the role of circulation is to provide mechanical cues, to deliver oxygen or to circulate signaling molecules. Here, we used time-lapse confocal microscopy to determine the role of fluid-derived forces in vessel remodeling in the developing murine yolk sac. Novel methods were used to characterize flows in normal embryos and in embryos with impaired contractility (Mlc2a^(–/–)). We found abnormal plasma and erythroblast circulation in these embryos, which led us to hypothesize that the entry of erythroblasts into circulation is a key event in triggering vessel remodeling. We tested this by sequestering erythroblasts in the blood islands, thereby lowering the hematocrit and reducing shear stress, and found that vessel remodeling and the expression of eNOS (Nos3) depends on erythroblast flow. Further, we rescued remodeling defects and eNOS expression in low-hematocrit embryos by restoring the viscosity of the blood. These data show that hemodynamic force is necessary and sufficient to induce vessel remodeling in the mammalian yolk sac
Additional Information
Published by The Company of Biologists 2007. Accepted 5 July 2007. First published online August 24, 2007. We thank both anonymous reviewers for improving the manuscript, Margaret Baron for Tg({epsilon}-globin-GFP) mice and for helpful discussions, Karen Hirschi and members of the Hirschi group for reading the manuscript and for helpful discussions and Josephine Enciso for the PECAM-1 antibody. This work was supported by R01 HL HL077187 (M.E.D.), a T32 HL7676 Training Grant supporting J.L.L. and an AHA Graduate Fellowship for E.A.V.J. Supplementary material for this article is available at http://dev.biologists.org/cgi/content/full/134/18/3317/DC1.Attached Files
Published - LUCdev07.pdf
Supplemental Material - DEV02883FigS1.jpg
Supplemental Material - DEV02883FigS2.jpg
Supplemental Material - DEV02883_Movie1.mov
Supplemental Material - DEV02883_Movie2.mov
Files
Name | Size | Download all |
---|---|---|
md5:409df88b312f4b7bc1be5070dd0ae4a8
|
97.8 kB | Preview Download |
md5:a6e8cc354836d9135c01927c511532fa
|
472.2 kB | Download |
md5:5c8047f22dea9b627fae4fdd7ee4c230
|
1.9 MB | Download |
md5:a1fb559beb12648f0a7d414acd6d2738
|
215.2 kB | Preview Download |
md5:22305f6fbaff03432b6c00a5f451a86a
|
3.8 MB | Preview Download |
md5:5a9559599186f15ae8034fe8e1e774a4
|
2.3 kB | Preview Download |
md5:dff800ecb10d8f936771812e99720062
|
13.7 kB | Preview Download |
Additional details
- Eprint ID
- 12052
- Resolver ID
- CaltechAUTHORS:LUCdev07
- NIH
- R01 HL HL077187
- NIH
- T32 HL7676
- American Heart Association
- Created
-
2008-10-21Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field